|
The objectives of the ProVac initiative are:
|
1) |
Strengthen infrastructure and processes for decision-making in the LAC Region. This includes: |
|
- Assessment of current decision-making process and current advisory bodies.
|
|
|
|
- Support for the formation of multidisciplinary country teams for data collection and cost-effectiveness (C/E) analysis.
|
|
- Establishment of a regional network of key centers of excellence in health costing.
|
|
2) |
Develope tools to assist with economic analysis and provide training to users: |
|
- Develop consistent and comparable models (costing and C/E models for conjugate pneumococcal, rotavirus, influenza and HPV).
|
|
- Establish the ProVac e-Support Center, which includes:
- ProVac models and tools for data collection
- OLIVES data repository
- ProVac E-Learning Courses |
|
- ProVac workshops and other training activities.
|
|
3) |
Implement these tools with standardized methods: |
|
- In 2008, ProVac performed cost-effectiveness analysis on pnuemococcal vaccine in Honduras, Ecuador, and Paraguay.
|
|
- In 2009, ProVac performed cost-effectiveness analysis on pneumococcal vaccine in Argentina, Bolivia, Nicaragua, and Venezuela.
|
|
4) |
Advocate for evidence-based decisions that consider the different components of the framework of evidence for vaccine introduction: |
|
- Support countries in generation of a technical report with the complete framework of evidence to make a decision (including technical, logistic, and societal criteria).
|
|
- Generation of a "decision case" for advocacy based on the evidence.
|
|
- Dissemination of the "decision case" to all levels of the decision-making process in the country.
|
|
5) |
Assist countries in effectively planning for vaccine introduction when evidence supports it: |
|
|
- Support countries in the development of a Plan of Action (PoA) for vaccine introduction.
Back to About ProVac |
|
ProVac's objectives 
